Fosun Pharma: Medical service layout next city buy rating

Investment Point Company announced on December 8th that Fosun Hospital, the company's controlling subsidiary, had signed the Investment Cooperation Framework Agreement with Zigong City Mental Health Center to reach a cooperation intention on cooperation in the construction and construction of a specialist geriatric hospital.
The two sides intend to jointly fund the establishment of Zigong City Geriatric Hospital Co., Ltd. (for-profit hospital, the company accounted for not less than 51%), the hospital planning covers an area of about 180 acres, is expected to set up 2,000 medical beds, 1,000 old-age beds.
company joined hands with the southwest first-class geriatric specialist hospital, jointly build the domestic first-class, with international standards of the third-level A geriatric specialist hospital, and to build it into the southwest region first-class geriatric care center. Since Gong City Mental Health Center Geriatrics Department for Sichuan Province Class A key specialty project construction projects, psychiatric department for Sichuan Province Class B key disciplines, the annual outpatient volume of more than 100,000 people, the annual admission of more than 10,000 inpatients. The hospital has 730 employees, including 1 expert who enjoys the national government subsidy, 1 academic technology leader of the provincial health department, 2 academic technology leaders from Zigong City, 1 master's tutor from Southwest Medical University, and 1 Chinese medicine practitioner from Sichuan Province. With health professional and technical personnel 627 people, including 55 senior titles, intermediate titles 107 people.
set up 850 beds, open beds 2300. There are 21 functional departments, 21 clinical departments and 7 medical and technical departments, of which the clinical department has 1 psychiatric intensive care ward (PICU), 1 chronic psychiatric ward, 4 general psychiatric wards, 2 cardiovascular wards, 12 geriatric wards and 1 each in general medicine, theology, surgery, gynecology, and Chinese medicine wards. The hospital has 1.5T MRI, Philips CT, fully automatic bio-chemical analyzer, imported color super, CR, transcranial magnetic stimulator, brain rise and fall graph, automatic blood cell counter, video electroencephalogram, dynamic electroencephalogram, Eye movement detector, transcranial Doppler, MECT treatment instrument, psychological CT, electronic endoscope, laparoscopy, C arm, gynecological LEEP knife, multiconductive sleep monitoring system and other equipment and neurorehabilitation system, physiotherapy and other rehabilitation equipment.
company's medical services continue to land, the leading edge is obvious. Companies in Beijing, Shanghai, Shandong, Zhejiang, Jiangsu, Hunan, Anhui, Guangdong, Guangxi, Sichuan and other places layout of about 20 hospitals (groups), including general hospitals, oncology hospitals, geriatric hospitals, women's and children's hospitals, chest and heart specialist hospitals, auxiliary reproductive hospitals, and most of them are high-quality level A and other for-profit hospitals. The total number of approved beds at Zen City Hospital, Jimin Hospital, Guangji Hospital, Zhongwu Hospital and Wenzhou Geriatric Hospital, which are controlled by the Company, is 3,018. We expect the number of hospital beds to reach 10,000 by 2020 as the co-built hospital continues to land.
company is the domestic single drug resistance leader, consistent evaluation leader and cell therapy leader. 1. The company has a total of 8 products approved clinically, including 5 biosimilar drugs and 3 bio-innovative drugs, heavy biosimilar drug research and development progress in China first; Alfa osteophenidol, benzodiamin chloride, aspirin and amitin hydrochloride are expected to be the first generic drugs to pass a consistent evaluation; Fosun Kate has followed the national GMP standards, in accordance with kite production process design concept, built an advanced cell preparation ultra-clean laboratory, is fully promoting Kite approved product KTE-C19 (commodity name Yescarta) technology transfer, preparation verification and other work. (China-Thai Securities)